Variable | Ceftriaxone (Group A) N = 113 | Cefepime (Group B) N = 117 | p-value |
---|---|---|---|
Age (years) | |||
Median | 29 | 30 | 0.3229 |
IQR | 14–40 | 21–40 | |
Age group | |||
<21 years | 40 (35.40 %) | 29 (24.79 %) | 0.292 |
21–40 years | 48 (42.48 %) | 60 (51.28 %) | |
41–60 years | 23 (20.35 %) | 24 (20.51 %) | |
>60 years | 2 (1.77 %) | 4 (3.42 %) | |
Sex | |||
Males | 77 (68.1 %) | 81 (69.2 %) | 0.562 |
Females | 36 (31.9 %) | 32 (30.8 %) | |
Level of education | |||
Primary | 56 (49.6 %) | 56 (47.9 %) | 0.859 |
Secondary | 44 (38.9 %) | 48 (41.0 %) | |
Tertiary | 9 (8.0 %) | 8 (6.8 %) | |
Informal | 4 (3.5 %) | 5 (4.3 %) | |
Occupation | |||
Employed | 38 (33.63 %) | 39 (33.33 %) | 0.095 |
Unemployed | 35 (30.97 %) | 50 (42.74 %) | |
Dependant | 40 (35.40 %) | 28 (23.93 %) | |
Mode of Health Care Financing | |||
Out of Pocket | 90 (79.65 %) | 91 (77.78 %) | 0.729 |
Health Insurance | 23 (20.35 %) | 26 (22.22 %) |